ArticleJournal for immunotherapy of cancer2023

TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma.

Maximilian O Schaettler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.